Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer

Advanced prostate cancers frequently develop resistance to androgen-deprivation therapy with serious implications for patient survival. Considering their importance in this type of neoplasia, epigenetic modifications have drawn attention as alternative treatment strategies. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Nair, Pacheco, Mariana Brütt, Soares-Fernandes, Diana, Correia, Margareta P., Camilo, Vânia, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391120/
https://www.ncbi.nlm.nih.gov/pubmed/34440180
http://dx.doi.org/10.3390/biomedicines9080976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391120/
https://www.ncbi.nlm.nih.gov/pubmed/34440180
http://dx.doi.org/10.3390/biomedicines9080976

Ejemplares similares